Folgen
Cristina Di Poto
Cristina Di Poto
Senior Scientist at AstraZeneca
Bestätigte E-Mail-Adresse bei astrazeneca.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis
HW Ressom, JF Xiao, L Tuli, RS Varghese, B Zhou, TH Tsai, ...
Analytica chimica acta 743, 90-100, 2012
1662012
LC–MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort
JF Xiao, RS Varghese, B Zhou, MR Nezami Ranjbar, Y Zhao, TH Tsai, ...
Journal of proteome research 11 (12), 5914-5923, 2012
1472012
LC‐MS/MS‐based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma
TH Tsai, E Song, R Zhu, C Di Poto, M Wang, Y Luo, RS Varghese, ...
Proteomics 15 (13), 2369-2381, 2015
892015
YAP/TAZ inhibition induces metabolic and signaling rewiring resulting in targetable vulnerabilities in NF2-deficient tumor cells
SM White, ML Avantaggiati, I Nemazanyy, C Di Poto, Y Yang, M Pende, ...
Developmental cell 49 (3), 425-443. e9, 2019
832019
GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort
MR Nezami Ranjbar, Y Luo, C Di Poto, RS Varghese, A Ferrarini, ...
PloS one 10 (6), e0127299, 2015
822015
Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma
A Ferrarini, C Di Poto, S He, C Tu, RS Varghese, A Kara Balla, ...
Journal of proteome research 18 (8), 3067-3076, 2019
672019
LC–MS profiling of N-glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma
TH Tsai, M Wang, C Di Poto, Y Hu, S Zhou, Y Zhao, RS Varghese, Y Luo, ...
Journal of proteome research 13 (11), 4859-4868, 2014
592014
Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients
E Cova, C Cereda, A Galli, D Curti, C Finotti, C Di Poto, M Corato, ...
Neuroscience letters 399 (3), 186-190, 2006
592006
Metabolomic characterization of hepatocellular carcinoma in patients with liver cirrhosis for biomarker discovery
C Di Poto, A Ferrarini, Y Zhao, RS Varghese, C Tu, Y Zuo, M Wang, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (5), 675-683, 2017
532017
INDEED: Integrated differential expression and differential network analysis of omic data for biomarker discovery
Y Zuo, Y Cui, C Di Poto, RS Varghese, G Yu, R Li, HW Ressom
Methods 111, 12-20, 2016
322016
Multi-profile Bayesian alignment model for LC-MS data analysis with integration of internal standards
TH Tsai, MG Tadesse, C Di Poto, LK Pannell, Y Mechref, Y Wang, ...
Bioinformatics 29 (21), 2774-2780, 2013
322013
2-DE and LC-MS/MS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies
I Passadore, P Iadarola, C Di Poto, S Giuliano, C Montecucco, L Cavagna, ...
Journal of proteome research 8 (5), 2331-2340, 2009
272009
Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming
S Su, C Di Poto, R Roy, X Liu, W Cui, A Kroemer, HW Ressom
Experimental Biology and Medicine 244 (11), 857-864, 2019
252019
Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection
C Di Poto, S He, RS Varghese, Y Zhao, A Ferrarini, S Su, A Karabala, ...
PLoS One 13 (3), e0192748, 2018
252018
Effect of nitric oxide on lymphocytes from sporadic amyotrophic lateral sclerosis patients: toxic or protective role?
C Cereda, E Cova, C Di Poto, A Galli, G Mazzini, M Corato, M Ceroni
Neurological Sciences 27, 312-316, 2006
192006
DNA methylation activates TP73 expression in hepatocellular carcinoma and gastrointestinal cancer
Z Yao, C Di Poto, G Mavodza, E Oliver, HW Ressom, ZA Sherif
Scientific reports 9 (1), 19367, 2019
182019
Simat: Gc-sim-ms data analysis tool
MR Nezami Ranjbar, CD Poto, Y Wang, HW Ressom
BMC bioinformatics 16, 1-12, 2015
172015
Metabolomic profiling of human urine samples using LC-TIMS-QTOF mass spectrometry
C Di Poto, X Tian, X Peng, HM Heyman, M Szesny, S Hess, LH Cazares
Journal of the American Society for Mass Spectrometry 32 (8), 2072-2080, 2021
122021
Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis
J Xiao, Y Zhao, RS Varghese, B Zhou, C Di Poto, L Zhang, MG Tadesse, ...
Cancer Epidemiology, Biomarkers & Prevention 23 (1), 64-72, 2014
122014
2‐DE and MALDI‐TOF‐MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis
C Di Poto, P Iadarola, AM Bardoni, I Passadore, S Giorgetti, C Cereda, ...
Electrophoresis 28 (23), 4320-4329, 2007
122007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20